Background: The recurrence rate of bipolar disorder (BD) is relatively high. Assessing the risk of relapse in patients with BD can assist in identifying populations at high risk for recurrence, and early feasible interventions can improve patient' prognoses. Therefore, it is important to establish and validate predictive models for relapse risk in patients with BD.
Method: We used 303 patients with BD admitted to the Anhui Mental Health Center as a retrospective training cohort and 81 patients from the Wuhu Fourth People's Hospital as an external validation cohort. We collected a multidimensional assessment of the characteristics of patients eligible for enrollment, including general demographic characteristics, medical history, treatment, and assessment of selected scales. At the same time, they were followed up for 1 year after reaching the recovery standard after treatment. Depending on whether their symptoms returned within a year, patients with BD were divided into recurrent and non-recurrent groups. Recurrence risk factors for BD were selected using univariate and binary logistic regression analyses based on the clinical data of the patients and other pertinent information. A nomogram model was developed to predict the incidence of BD relapse. To further assess the model fit and dependability, calibration curves, working curves of subject attributes, and decision curves were also employed.
Result: A total of 384 patients with BD were enrolled in this study, of whom 250(65.1%) had non-recurrent episodes and 134(34.9%) had recurrent episodes. Of these, 96 (31.7%) had relapses at the Anhui Mental Health Centre and 38 (46.9%) at the Fourth People's Hospital of Wuhu City. According to the results of univariate and multivariate logistic regression analyses, the number of prior episodes (odds ratio [OR]: 1.38, 95% confidence interval [CI]: 1.179-1.615), Social Disability Screening Schedule (SDSS) score (OR: 1.303, 95% CI: 1.027-1.652), Pittsburgh Sleep Quality Index (PSQI) (OR: 1.476, 95% CI: 1.29-1.689), Number of visits(OR: 0.768, 95% CI: 0.684-0.863), suicidal behaviors (OR: 5.54, 95% CI: 1.818-16.881) and the electroconvulsive therapy (ECT) (OR: 0.382, 95% CI: 0.156-0.94) were independent risk factors for relapse in patients with BD. An analysis of the receiver operating characteristic curve, calibration curve, and clinical decision curve further revealed that the predictive efficiency and degree of fit between the predicted value of the nomogram and the actual observed value were better.
Conclusion: This study found that the number of previous episodes, SDSS score, PSQI score and suicidal behaviors were independent risk factors for relapse of BD, while the number of visits and ECT were protective factor. Based on these factors, we developed and validated a nomogram for predicting relapse in patients with BD; that has clinical reference values.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11779737 | PMC |
http://dx.doi.org/10.3389/fpsyt.2024.1500892 | DOI Listing |
S Afr J Surg
December 2024
Department of Gastrointestinal Surgery, Central Hospital Affiliated to Shandong First Medical University, China.
Retroperitoneal lymphangioma is exceptionally rare. We present a case of a 41-year-old asymptomatic patient with a large abdominal cystic mass detected on contrast-enhanced computed tomography (CT) scan, initially suspected to be pseudomyxoma peritonei. Laparoscopic exploration revealed a 30 x 30 cm multilocular cystic tumour originating from the retroperitoneum.
View Article and Find Full Text PDFJ Endourol
January 2025
Department of Urology, Peking University First Hospital, Beijing, China.
We aim to compare the clinical outcomes of radical nephroureterectomy with bladder cuff removal (RNU) and segmental resection with ureteral reimplantation (RR) in Chinese patients with distal ureteral urothelial carcinoma. A retrospective analysis of medical records was performed for 922 patients found to have distal ureteral cancer, defined as below the level of the iliac vessels, with 747 patients who underwent RNU and 175 who underwent RR included in the final analysis. The primary endpoints included clinical outcomes and changes in the estimated glomerular filtration rate (eGFR).
View Article and Find Full Text PDFCureus
December 2024
Family Medicine, Augusta University Medical College of Georgia, Chatsworth, USA.
Hairy cell leukemia (HCL) is a rare, chronic B-cell malignancy with an indolent course that typically responds well to purine nucleoside analogs, such as cladribine. We present the case of a 74-year-old woman with nearly three decades of recurrent HCL, marked by multiple relapses and significant toxicities to various treatments, including purine analogs, BRAF inhibitors, BTK inhibitors, a cytoreductive agent, and the monoclonal antibody rituximab. Despite severe allergic reactions and intolerances to standard therapies, the patient achieved multiple remissions.
View Article and Find Full Text PDFCureus
December 2024
Radiology, The Second Health Cluster, Jeddah, SAU.
Intussusception is a leading cause of acute intestinal obstruction in infants, typically presenting with a classic triad of intermittent abdominal pain, vomiting, and currant jelly stools. However, atypical presentations can lead to diagnostic delays, increasing the risk of complications. This report describes a seven-month-old male with an unusual presentation of lethargy and irritability, without overt gastrointestinal symptoms.
View Article and Find Full Text PDFFront Oncol
January 2025
Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Introduction: This retrospective study aims to evaluate the long-term efficacy and urinary toxicity of LDR-brachytherapy for localized prostate cancer.
Materials And Methods: 235 primary prostate cancer patients treated with LDR-brachytherapy and subsequently followed up in our center were included in this study. Biochemical relapse free survival (bRFS), overall survival (OS), and cancer-specific survival (CSS) were evaluated.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!